Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DUAVEE | WYETH PHARMS | N-022247 RX | 2013-10-03 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MILPREM-400 | Medpointe Pharm Hlc | N-011045 DISCN | 1982-01-01 | 1 products |
MILPREM-200 | Medpointe Pharm Hlc | N-011045 DISCN | 1982-01-01 | 1 products |
PMB 400 | Wyeth | N-010971 DISCN | 1982-01-01 | 1 products |
PMB 200 | Wyeth | N-010971 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
cenestin | New Drug Application | 2004-09-01 |
duavee | New Drug Application | 2023-11-01 |
enjuvia | New Drug Application | 2010-03-01 |
menest | ANDA | 2019-09-19 |
premarin | New Drug Application | 2023-12-03 |
premphase | ANDA | 2012-11-26 |
premphase prempro | New Drug Application | 2023-11-29 |
prempro | New Drug Application | 2020-05-28 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 219 | 614 | 276 | 41 | 208 | 1263 |
Infertility | D007246 | HP_0000789 | — | 11 | 18 | 30 | 46 | 54 | 148 |
Menopause | D008593 | EFO_0003922 | N95 | 17 | 20 | 20 | 26 | 33 | 112 |
Healthy volunteers/patients | — | — | — | 78 | 8 | 5 | 4 | 13 | 103 |
Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | 4 | 10 | 17 | 27 | 40 | 94 |
Neoplasms | D009369 | — | C80 | 43 | 36 | 4 | 1 | 11 | 82 |
Contraception | D003267 | — | — | 10 | 12 | 24 | 18 | 14 | 76 |
Triple negative breast neoplasms | D064726 | — | — | 27 | 49 | 6 | 1 | 2 | 71 |
Osteoporosis | D010024 | HP_0000939 | M81.0 | 6 | 12 | 20 | 11 | 16 | 64 |
Postmenopause | D017698 | — | — | 10 | 11 | 14 | 5 | 16 | 54 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Prostatic neoplasms | D011471 | — | C61 | 8 | 33 | 13 | — | 8 | 56 |
Endometrial neoplasms | D016889 | EFO_0004230 | — | 7 | 35 | 6 | — | 6 | 48 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 11 | 24 | 6 | — | 2 | 38 |
Coronary disease | D003327 | — | — | — | 2 | 11 | — | 5 | 17 |
Ductal carcinoma breast | D018270 | — | — | 5 | 7 | 4 | — | 3 | 16 |
Adenocarcinoma | D000230 | — | — | 3 | 11 | 2 | — | 1 | 15 |
Arthralgia | D018771 | HP_0002829 | M25.5 | — | 3 | 2 | — | 10 | 15 |
Fallopian tube neoplasms | D005185 | — | — | 1 | 7 | 4 | — | — | 12 |
Premature birth | D047928 | EFO_0003917 | O60 | 1 | 2 | 7 | — | 4 | 12 |
Pain | D010146 | EFO_0003843 | R52 | 2 | 6 | 3 | — | 3 | 11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 11 | 8 | — | — | 1 | 16 |
Thrombocytopenic purpura idiopathic | D016553 | EFO_0007160 | D69.3 | 1 | 8 | — | — | — | 8 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 4 | 4 | — | — | 1 | 8 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | 4 | 4 | — | — | — | 7 |
Central nervous system neoplasms | D016543 | — | — | 1 | 6 | — | — | — | 6 |
Endometrioid carcinoma | D018269 | — | — | 2 | 3 | — | — | — | 5 |
Pulmonary arterial hypertension | D000081029 | — | — | — | 5 | — | — | — | 5 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | 2 | — | — | 1 | 4 |
Colorectal neoplasms | D015179 | — | — | 4 | 4 | — | — | — | 4 |
Small cell lung carcinoma | D055752 | — | — | 4 | 2 | — | — | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Therapeutic equivalency | D013810 | — | — | 11 | — | — | — | 1 | 12 |
Drug interactions | D004347 | — | — | 4 | — | — | — | 2 | 6 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | — | — | — | 2 | 3 |
Kallmann syndrome | D017436 | Orphanet_478 | E23.0 | 1 | — | — | — | 2 | 3 |
Hyperinsulinism | D006946 | HP_0000842 | E16.1 | 1 | — | — | — | 2 | 3 |
Hepatitis c | D006526 | — | B19.2 | 3 | — | — | — | — | 3 |
Leukemia | D007938 | — | C95 | 1 | — | — | — | 1 | 2 |
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | 2 | — | — | — | — | 2 |
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | 1 | — | — | — | 1 | 2 |
Sleep | D012890 | GO_0030431 | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Menstrual cycle | D008597 | — | — | — | — | — | — | 4 | 4 |
Blood pressure | D001794 | EFO_0004325 | — | — | — | — | — | 3 | 3 |
Premature menopause | D008594 | HP_0008209 | E28.31 | — | — | — | — | 3 | 3 |
Vascular stiffness | D059289 | — | — | — | — | — | — | 3 | 3 |
Headache | D006261 | HP_0002315 | R51 | — | — | — | — | 3 | 3 |
Mood disorders | D019964 | EFO_0004247 | F30-F39 | — | — | — | — | 3 | 3 |
Gender identity | D005783 | — | — | — | — | — | — | 3 | 3 |
Pregnancy rate | D018873 | — | — | — | — | — | — | 2 | 2 |
Feeding behavior | D005247 | — | — | — | — | — | — | 2 | 2 |
Glucose metabolism disorders | D044882 | — | — | — | — | — | — | 2 | 2 |
Drug common name | Estrogens conjugated |
INN | — |
Description | Conjugated estrogens (CEs), or conjugated equine estrogens (CEEs), sold under the brand name Premarin among others, is an estrogen medication which is used in menopausal hormone therapy and for various other indications. It is a mixture of the sodium salts of estrogen conjugates found in horses, such as estrone sulfate and equilin sulfate. CEEs are available in the form of both natural preparations manufactured from the urine of pregnant mares and fully synthetic replications of the natural preparations. They are formulated both alone and in combination with progestins such as medroxyprogesterone acetate. CEEs are usually taken by mouth, but can also be given by application to the skin or vagina as a cream or by injection into a blood vessel or muscle.
|
Classification | Unknown |
Drug class | estrogens |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 12126-59-9 |
RxCUI | — |
ChEMBL ID | CHEMBL1201649 |
ChEBI ID | — |
PubChem CID | 656613 |
DrugBank | DB00286 |
UNII ID | — |